Twist Bioscience
TWST
103.32
-8.30
-7.44%
Twist Bioscience
US · TWST
#1258 by market cap
Listed 2018
103.32
-8.30
-7.44%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:52
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 40 in the most recent period (2026/Q3).
- Total institutional ownership rose 3.0 percentage points.
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 127.93% +3.03pp
- Institutions
- 447 +40
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund104.36%
Hedge Fund14.93%
Public Company4.90%
Private Company1.66%
Government Pension Fund1.36%
Individual/Insider1.31%
Insurance Company0.54%
VC/PE Fund0.10%
Top holders as of 2026-08-31
FMR
13.97% · 8.76M sh
BlackRock
9.30% · 5.83M sh
Artisan Partners Limited Partnership
7.66% · 4.80M sh
T. Rowe Price Group, Inc.
6.75% · 4.23M sh
ARK Investment Management LLC
5.40% · 3.39M sh
State Street Global Advisors
5.15% · 3.23M sh
Vanguard Capital Management, LLC
5.01% · 3.14M sh
Vanguard Portfolio Management, LLC
4.51% · 2.82M sh
EdgePoint Investment Group Inc.
4.02% · 2.52M sh
William Blair Investment Management, LLC
3.97% · 2.49M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 0 buys · 50 sells
| Name | Role | Stake |
|---|---|---|
| Emily Leproust | Co-Founder, Board Chair & CEO | 0.50% |
| Paula Green | Officer | 0.17% |
| Keith Crandell | Independent Director | 0.17% |
| Patrick Finn | President | 0.11% |
| Robert Chess | Lead Independent Director | 0.10% |
| Adam Laponis | Chief Financial Officer | 0.05% |
| Nelson Chan | Independent Director | 0.04% |
| Robert Ragusa | Independent Director | 0.04% |
| Dennis Cho | Chief Legal Officer | 0.03% |
| Katryn Blake | Independent Director | 0.03% |
| Melissa Starovasnik | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-02 | Emily Leproust | Co-Founder, Board Chair & CEO | Open Market Disposition | -4,573 | $135.40 |
| 2026-11-02 | Robert Werner | Vice President | Open Market Disposition | -148 | $135.40 |
| 2026-11-02 | Patrick Finn | President | Open Market Disposition | -2,565 | $135.40 |
| 2026-11-02 | Paula Green | Officer | Open Market Disposition | -1,007 | $135.40 |
| 2026-11-02 | Dennis Cho | Chief Legal Officer | Open Market Disposition | -949 | $135.40 |
| 2026-10-22 | Patrick Finn | President | Open Market Disposition | -2,245 | $134.59 |
| 2026-10-08 | Adam Laponis | Chief Financial Officer | Open Market Disposition | -2,462 | $156.30 |
| 2026-10-04 | Emily Leproust | Co-Founder, Board Chair & CEO | Automatic Disposition | -4,548 | $200.44–207.46 |
| 2026-10-04 | Emily Leproust | Chairperson & CEO | Intent to Sell (Form 144) | -4,548 | $202.15 |
| 2026-10-01 | Emily Leproust | Co-Founder, Board Chair & CEO | Open Market Disposition | -45,736 | $188.88 |
| 2026-10-01 | Robert Werner | Vice President | Open Market Disposition | -1,482 | $188.88 |
| 2026-10-01 | Patrick Finn | President | Open Market Disposition | -25,714 | $188.88 |
| 2026-10-01 | Paula Green | Officer | Open Market Disposition | -10,088 | $188.88 |
| 2026-10-01 | Adam Laponis | Chief Financial Officer | Open Market Disposition | -8,057 | $188.88 |
| 2026-10-01 | Dennis Cho | Chief Legal Officer | Open Market Disposition | -9,514 | $188.88 |
| 2026-09-30 | Emily Leproust | Co-Founder, Board Chair & CEO | Automatic Disposition | -655 | $200.00 |
| 2026-09-23 | Emily Leproust | Co-Founder, Board Chair & CEO | Automatic Disposition | -5,203 | $175.23–184.60 |
| 2026-09-20 | Emily Leproust | Co-Founder, Board Chair & CEO | Open Market Disposition | -1,687 | $165.49 |
| 2026-09-20 | Paula Green | Officer | Open Market Disposition | -294 | $165.49 |
| 2026-09-20 | Dennis Cho | Chief Legal Officer | Open Market Disposition | -348 | $165.49 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:52:04 · For reference only, not investment advice and not tailored to your situation.
Twist Bioscience discussion 0 comments